246
Views
1
CrossRef citations to date
0
Altmetric
REPORTS

Transitioning a Cancer Patient From High-Dose Intravenous Hydromorphone Therapy to Intravenous Methadone

, , , &
Pages 356-361 | Published online: 29 Nov 2011

REFERENCES

  • Leppert W. The role of methadone in cancer pain treatment—a review. Int J Clin Pract. 2009;63:1095–1109.
  • Manfreidi, PL, Borsook D, Chandler SW, Payne, R. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations. Pain. 1997;70:99–101.
  • Ripamonti C, Bianchi M. The use of methadone for cancer pain. Hematol Oncol Clin N Am. 2002;16:543–555.
  • Shaiova L, Berger A, Blinderman CD, Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care. 2008;6:165–176.
  • Weschules DJ, Bain KT. A systematic review of opioid conversation ratios used with methadone for the treatment of pain. Pain Med. 2008;9:595–612.
  • Pollock AB, Tegeler ML, Morgan V, Baumrucker SJ. Morphine to methadone conversion: an interpretation of published data. Am J Hosp Palliat Care. 2011;28:135–140.
  • Fine PG, Portenoy RK. Establishing ‘best practices’ for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 2009;38:418–425.
  • Thomas Z, Bruera E. Use of methadone in a highly tolerant patient receiving parenteral hydromorphone. J Pain Symptom Manage. 1995;10:315–317.
  • American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 6th ed. Glenview, IL: American Pain Society; 2008:41–47.
  • McPherson ML. Methadone: a complex and challenging analgesic, but it's worth it (Chapter 6, pp. 107–143) and patient controlled analgesia (Chapter 7, 145–166). In: McPherson ML, ed. Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing. Bethesda, MD: American Society of Health-Systems Pharmacists; 2010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.